About NJ Bio
NJ Bio is a company based in North Brunswick (United States) founded in 2018 was acquired by Suven Pharmaceuticals in December 2024. NJ Bio has completed 1 acquisition, including L2P Research Labs. NJ Bio offers products and services including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services. NJ Bio operates in a competitive market with competitors including Liberation Labs, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nj Bio, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Suven Pharmaceuticals
(Dec 07, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NJ Bio
NJ Bio offers a comprehensive portfolio of products and services, including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services.
Specialized services for antibody-drug conjugate design and production
Custom manufacturing of biopharmaceutical compounds and linkers
Processes for linking payloads to antibodies in drug development
Analytical testing for drug efficacy and safety assessments
Synthesis and analysis of oligonucleotides for research needs
Development and production of mRNA-based therapeutic components
Custom synthesis of medicinal compounds for drug discovery
People of NJ Bio
Unlock access to complete
Unlock access to complete
Funding Insights of NJ Bio
Detailed funding history for NJ Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in NJ Bio
NJ Bio has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract manufacturing and development of APIs and formulations are provided.
|
Locked | Locked | Locked |
Investor details for NJ Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NJ Bio
NJ Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include L2P Research Labs.
Investment portfolio details for NJ Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
L2P Research Labs is engaged in clinical and non-clinical research.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for NJ Bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NJ Bio
Detailed financials for NJ Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nj Bio Comparisons
Peer comparison for NJ Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NJ Bio
NJ Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liberation Labs, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fermentation products are manufactured and commercialized via CRO services.
|
|
| Locked | Locked | Locked |
Chemical proteomics for cellular target profiling and drug discovery services
|
|
| Locked | Locked | Locked |
Drug discovery services are delivered via chemical-proteomics technologies.
|
|
| Locked | Locked | Locked |
Computational protein design solutions are delivered at scale.
|
|
| Locked | Locked | Locked |
CRO offering chemical proteomics services for preclinical development of drug
|
Detailed competitors of NJ Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nj Bio
Complete news archive for NJ Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NJ Bio
NJ Bio was founded in 2018.
NJ Bio is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
NJ Bio was founded in 2018 and is based in North Brunswick, United States. Clinical development services are offered by the company within the biotechnology sector. Operations focus on supporting drug development processes, including trial management and regulatory compliance. Expertise is applied to assist clients in advancing therapeutic candidates from preclinical stages through clinical trials. The firms activities are centered in the U.S., serving pharmaceutical and biotech partners.
NJ Bio's top competitors include Liberation Labs, Shantani Proteome Analytics and Kinaxo Biotechnologies.
NJ Bio offers ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and 3 more products and services.
NJ Bio has made 1 acquisition, including L2P Research Labs.
NJ Bio has 1 investor. Key investors include Suven Pharma.